Connecting clients, partners and patients to develop new treatments for diabetes and related metabolic diseases.

Science Driven Therapeutically Focused

Delivering on the Potential of Innovative Therapeutics for Metabolic Diseases

Advise • Advance • Achieve

Clinical Development and Regulatory Strategy + State-of-the-Art Clinical Facility + Full Scope CRO Services + Global Scientific Network

ProSciento Services

Specialty consulting services for clinical development, regulatory strategy and licensing.
State-of-the-art clinical research facilities for metabolic drug and device clinical trials.
Full scope, comprehensive multi-site services to support metabolic clinical research programs.
Global network of partners connecting our clients to the most innovative research methods.


March 23, 2017

ProSciento’s President and Chief Development Officer to Present at NASH Summit Read More »

February 15, 2017

mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population Read More »


View Our Presentation


April 18, 2017

Allergan, Novartis ink NASH partnership Read More »

April 16, 2017

NEJM study reports long-term mortality and CV disease outcomes for type 1 and type 2 diabetes Read More »

March 30, 2017

Nature study highlights novel diabetes drug with potential to restore insulin sensitivity in mice Read More »